$7.08M Rev – High-Margin Dental Device Platform

This U.S.-based dental medical device company has commercialized a proprietary chairside technology that significantly improves the clinical efficacy and patient experience of local anesthesia. Operating a proven, recurring-revenue business model with industry-leading gross margins, the business is currently executing a strategic product transition from a legacy reusable system to a fully disposable device designed for mass scalability. The opportunity is supported by strong unit economics and recent market validation from a global pharmaceutical competitor entering the space, effectively de-risking the category. The company is now seeking growth capital to leverage these favorable dynamics, expand its direct and channel sales, and capture a substantial portion of the untapped addressable market.